A spotlight will be on issues such as artificial intelligence, gene therapy and bio-engineered corneas.
The answers to some of the biggest questions facing ophthalmology will be discussed at the first Australian Advances in Ophthalmology event hosted by RANZCO later this year.
Following the success of its fully-fledged virtual congress in February, the college’s new one-day conference will also be delivered digitally, covering a variety of topics including artificial intelligence (AI), gene therapy and bio-derived corneas. -engineering.
Taking place on Saturday 10 September 2022, the event is open to all and will be hosted by Sydney-based ophthalmologists Professor Peter McCluskey and Associate Professor Clare Fraser.
Ultimately, it aims to find out what the next five years of ophthalmic developments will mean for members of the eye care team, their patients and their communities.
Ophthalmologists will be invited to consider how these developments and advancements will affect the practice of ophthalmology. And, more importantly, how they can harness these changes to improve the lives of the communities they serve.
The conference will include panels, debates, live interactions and Q&A. Discussions include:
- Professor David Mackey explores whether self-driving cars will ever be suitable for the visually impaired.
- Professor Gerard Sutton wonders if a bio-engineered cornea would work.
- The conclusion of the program will be a discussion about AI and what it means for ophthalmologists, patients and the community.
Participants will also gain a better understanding of stem cell Rx and antimicrobial stewardship.
This is the first time that RANZCO has hosted an advances in ophthalmology event, with plans to host it again as an in-person meeting in the first half of 2023.
Event information is available on the Advances in Ophthalmology website. Registration is now open.
RANZCO congress highlights new horizons in ophthalmology
RANZCO Position Paper on Myopia: Why Outdoor Time Matters
RANZCO appoints Mark Carmichael as CEO